PhD student
Virginia Commonwealth University
Hadi Sudarjat Pharm.D., MPharm is a Ph.D. candidate from the Department of Pharmaceutics, Virginia Commonwealth University. His current project is working to develop a novel formulation of LAAM for Opioid Use Disorder (OUD) treatment. He developed a transmucosal dosage form of LAAM in order to improve its efficacy which may improve patient compliance. Previously, Hadi was working as a clinical pharmacist in Indonesia for 2 years before enrolling in a master's degree to focus on research at the University of Indonesia. In his master's thesis, Hadi focuses on the development of gold nanoparticles for cancer and also on endogenous medicine for tropical diseases such as malaria and dengue.